New Delhi : India’s drug regulatory organization is planning to launch a unified portal to develop a digital drugs regulatory system. The system will maintain a database of drugs that are not standard quality or are spurious to build trust in their quality across domestic and global markets.
A unified portal which will maintain a database of drugs that are not of standard quality or are spurious is in the offing.
With an aim to build trust on the quality of drugs in the domestic and global markets, India’s drug regulatory organisation is all set to introduce a new unified portal for developing a digital drugs regulatory system (DRS).
The drug regulator has asked for suggestions from various government agencies over the proposed portal including all state drug controllers, customs, ministry of environment, drug manufacturing associations, Indian Council of Medical research, Bureau ofIndian Standards (BIS), among others.